Previous 10 | Next 10 |
2023-03-05 17:35:00 ET Zynex ( NASDAQ: ZYXI ) is scheduled to announce Q4 earnings results on Monday, March 6th, after market close. The consensus EPS Estimate is $0.18 (-21.7% Y/Y) and the consensus Revenue Estimate is $49.72M (+23.2% Y/Y). Over the la...
Zynex, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results PR Newswire ENGLEWOOD, Colo. , Feb. 23, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-inva...
Zynex ( NASDAQ: ZYXI ) leased a new 41K sq. foot facility for its Zynex Monitoring Solution's (ZMS) current and expected future growth. The new ZMS facility is located within a quarter mile of Zynex Medical Headquarters on Maroon Drive in Englewood, Colorado, and th...
Zynex Leases New Facility to Accommodate Growth PR Newswire ENGLEWOOD, Colo. , Feb. 21, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pai...
Zynex Announces Inclusion in MSCI USA Small Cap Index PR Newswire ENGLEWOOD, Colo. , Feb. 17, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices f...
Zynex Monitoring Announces Community Blood Drive and Research Collaboration Trial for its Fluid Monitoring System PR Newswire ENGLEWOOD, Colo. , Feb. 1, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in...
Summary Products sold in the past by Zynex for pain management have failed to penetrate the market. Zynex's new products are radically different from their predecessors: more specific and innovative. The new products the company will market could grow sales far beyond analysts' expe...
Zynex Recognized in The Power 500 Healthcare Technology Companies PR Newswire ENGLEWOOD, Colo. , Jan. 31, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive m...
Summary Healthcare significantly outperformed the broader market last year, after two years of underperforming the S&P 500. When the end to restrictive policy is in sight, then the sector is likely to witness a group rotation to more growth-oriented stocks. Groups like medical d...
Summary Pharmaceuticals and biotechnology have the best value and quality scores in the sector. Healthcare providers are close to their historical baseline in valuation and quality. Fast facts on GNOM. 10 stocks cheaper than their peers in January. This monthly article...
News, Short Squeeze, Breakout and More Instantly...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...